| Target ID: | dt1050 |
|---|---|
| CID: | 23694214 |
| Compound Name: | Hydrocortisone Sodium Succinate |
| Gene ID: | 4780 |
| Gene Name: | NFE2L2 |
| Species: | Homo sapiens (human) |
| PubMed IDs: | -- |
| Action: | -- |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt1121 | 54670067 | Ascorbic Acid | 4780 | NFE2L2 | Homo sapiens (human) | -- | Details |
| dt1338 | 5744 | Hydrocortisone Acetate | 4780 | NFE2L2 | Homo sapiens (human) | -- | Details |
| dt444 | 12456 | Berberine Chloride | 4780 | NFE2L2 | Homo sapiens (human) | -- | Details |
| dt516 | 41684 | Nitazoxanide | 4780 | NFE2L2 | Homo sapiens (human) | -- | Details |
| dt578 | 126941 | Methotrexate | 4780 | NFE2L2 | Homo sapiens (human) | -- | Details |
| dt740 | 5280795 | Cholecalciferol | 4780 | NFE2L2 | Homo sapiens (human) | -- | Details |
| dt845 | 5479529 | Cefuroxime | 4780 | NFE2L2 | Mus musculus (house mouse) | Cefuroxime results in decreased activity of NFE2L2 protein | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug127 | hydrocortisone sodium succinate | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||